ARS Pharmaceuticals (SPRY) Is Down 11.5% After Losing Spots in Key Russell 2000 Defensive Indices
In late June 2026, ARS Pharmaceuticals, Inc. (NasdaqGM: SPRY) was removed from both the Russell 2000 Growth-Defensive Index and the Russell 2000 Defensive Index, altering its presence in widely followed small-cap benchmarks. This dual index removal could affect the company’s visibility and index-linked ownership, prompting investors to reassess how they monitor and access ARS Pharmaceuticals’ stock. We’ll now examine how ARS Pharmaceuticals’ removal from key Russell 2000 defensive indices...
In late June 2026, ARS Pharmaceuticals, Inc. (NasdaqGM: SPRY) was removed from both the Russell 2000 Growth-Defensive Index and the Russell 2000 Defensive Index, altering its presence in widely followed small-cap benchmarks. This dual index removal could affect the company’s visibility and index-linked ownership, prompting investors to reassess how they monitor and access ARS Pharmaceuticals’ stock. We’ll now examine how ARS Pharmaceuticals’ removal from key Russell 2000 defensive indices...
What's Your Reaction?
:max_bytes(150000):strip_icc()/GettyImages-2187410260-5afe56694791404f99c253dd8d5abe6a.jpg?#)
